Fujifilm

Fujifilm to Debut New Products for Broadcast, Cinema, and Digital Content Creators at NAB 2024

Retrieved on: 
Thursday, April 4, 2024
Instrument, Super 35, Fujifilm X series, NAB, Steadicam, Central Hall, Fujifilm, Lens, Sony, National Association, Calendar, NAB Show, Telescopic sight

VALHALLA, N.Y., April 04, 2024 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation’s Electronic Imaging and Optical Devices Divisions will debut a variety of new gear and technology at the 2024 National Association of Broadcasters Show (NAB 2024) from April 14 – 17, 2024 in Las Vegas.

Key Points: 
  • VALHALLA, N.Y., April 04, 2024 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation’s Electronic Imaging and Optical Devices Divisions will debut a variety of new gear and technology at the 2024 National Association of Broadcasters Show (NAB 2024) from April 14 – 17, 2024 in Las Vegas.
  • Duvo™ 25-1000mm was awarded Best Overall Product in the “CREATE” Category of the 2023 NAB Show “Product of the Year” Awards.
  • “The continual excitement around our products is constantly generating conversations and creating new avenues for customers to explore.
  • For more information about Fujifilm's presence at NAB 2024, click here .

Fujifilm Files Patent Infringement Lawsuit Against Eastman Kodak Company

Retrieved on: 
Wednesday, March 20, 2024
Fujifilm, Patent, Kodak, District court, KODK, Research, Sale, Unified Patent Court, Investment, 3D printing

HANOVER PARK, Ill., March 20, 2024 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation, Graphic Communication Division today announced that FUJIFILM Corporation filed a patent infringement lawsuit against Eastman Kodak Company (NYSE: KODK) in the United States District Court for the District of New Jersey.

Key Points: 
  • HANOVER PARK, Ill., March 20, 2024 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation, Graphic Communication Division today announced that FUJIFILM Corporation filed a patent infringement lawsuit against Eastman Kodak Company (NYSE: KODK) in the United States District Court for the District of New Jersey.
  • Fujifilm has asserted four patents (U.S. Patent Nos.
  • 10,427,443, 10,525,696, 10,875,346, and 11,294,279) pertaining to various aspects of processless lithographic printing plate technologies, including method and apparatus claims.
  • “We will enforce and protect our innovation and intellectual property rights in the United States and around the world when we believe others infringe unfairly.”
    Separately in October 2023 and December 2023 respectively, Eastman Kodak’s European subsidiaries, Kodak GmbH, Kodak Graphic Communications GmbH, and Kodak Holding GmbH, were sued by FUJIFILM Corporation for infringement of the related European counterparts of the US patents-in-suit in the Unified Patent Court and in Germany.

Fujifilm Demonstrates Commitment to and Investment in Education at the 2024 Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition

Retrieved on: 
Thursday, March 7, 2024
Cloud, Radiology, Architecture, Enterprise imaging, Artificial intelligence, AI, Education, MD, HIMSS, Cardiology, Health, Fujifilm, Organization, URG, VNA, Environment, Miller, AWS, PACS, Synapse

Fujifilm’s KLAS award-winning and government-validated Synapse® Enterprise Imaging solutions will be presented and available for demonstration in booth 4461.

Key Points: 
  • Fujifilm’s KLAS award-winning and government-validated Synapse® Enterprise Imaging solutions will be presented and available for demonstration in booth 4461.
  • These solutions include 7x Enterprise PACS, AI Orchestrator, VNA, EIS/RIS, 3D Advanced Visualization, Enterprise Imaging Analytics, Cloud Services, and Pathology PACS.
  • “Our vision has been laser focused on delivering the best possible enterprise imaging solution to meet our customers' growing needs.
  • “Our team looks forward to demonstrating how Fujifilm’s Synapse Enterprise Imaging portfolio is orchestrating AI and further innovating diagnostic workflows with AI results.

Fujifilm Announces Availability of FUJINON Duvo™ HZK24-300mm Portable PL Mount Zoom Lens: Wide, Light, and Long

Retrieved on: 
Thursday, March 7, 2024
NAB Show, Lens, Fujifilm, Fujinon, Steadicam, NAB, Telescopic sight

VALHALLA, N.Y., March 07, 2024 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation’s Optical Devices Division announces the availability of its new FUJINON Duvo™ HZK24-300mm Portable PL Mount Zoom Lens (”Duvo 24-300mm“).

Key Points: 
  • VALHALLA, N.Y., March 07, 2024 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation’s Optical Devices Division announces the availability of its new FUJINON Duvo™ HZK24-300mm Portable PL Mount Zoom Lens (”Duvo 24-300mm“).
  • Fujifilm expects to begin shipping initial orders of Duvo 24-300mm to customers at the end of March, 2024.
  • This versatile portable lens can be used with a tripod, shoulder-mounted with a Steadicam [2] , or for high-angle shooting, using a crane.
  • Complementing the previously released FUJINON Duvo™ HZK25-1000mm F2.8-F5.0 PL Mount Cinema Box Lens (“Duvo 25-1000mm”) — Fujifilm’s first Duvo Series lens — Duvo 24-300mm delivers 12.5x zoom, covering the frequently used 24-300mm focal range.

Fujifilm Receives 510(k) Clearance for SCALE EYE®, a Novel Endoscopic Imaging Technology for Measuring Colonic Lesions

Retrieved on: 
Monday, February 26, 2024
Polyp (medicine), Colonoscopy, FDA, Polyp, EYE, Risk, Fujifilm, Colorectal polyp, PMID, Malignancy, Instrument, Subjectivity, NYU Langone Health, SCALE, Neoplasm, Hepatology

LEXINGTON, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation, a leading provider of endoscopic imaging and endosurgical solutions, has been granted FDA 510(k) clearance for SCALE EYE, a new endoscopic imaging technology and part of its expanding ELUXEO Endoscopic Imaging System.

Key Points: 
  • LEXINGTON, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation, a leading provider of endoscopic imaging and endosurgical solutions, has been granted FDA 510(k) clearance for SCALE EYE, a new endoscopic imaging technology and part of its expanding ELUXEO Endoscopic Imaging System.
  • Measurement time was 2.8 seconds using SCALE EYE, compared to 8 seconds when measuring with forceps.
  • Comparing size measurement of colorectal polyps using a novel virtual scale endoscope, endoscopic ruler or forceps: A preclinical randomized trial.
  • Introduction and preliminary evaluation of novel endoscope with pinpoint laser technology for adequate size estimation of colon lesions.

Fujifilm Receives PACS Award for Naval Medical Center - San Diego

Retrieved on: 
Tuesday, February 20, 2024
Enterprise imaging, DOD, Cardiology, 3D, Radiology, Authority, Health, Fujifilm, Mammography, Organization, RMF, Risk Management Framework, PACS, Synapse, Medical imaging

Lexington, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation , a leading provider of diagnostic and enterprise imaging solutions, today announced that the company was selected to transform the enterprise radiology PACS at the Naval Medical Center - San Diego with Synapse® 7x – Fujifilm’s next-generation enterprise imaging platform.

Key Points: 
  • Lexington, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation , a leading provider of diagnostic and enterprise imaging solutions, today announced that the company was selected to transform the enterprise radiology PACS at the Naval Medical Center - San Diego with Synapse® 7x – Fujifilm’s next-generation enterprise imaging platform.
  • Synapse 7x unites data and imaging from radiology, mammography, cardiology, 3D and other enterprise imaging solutions on server-side rendering technology.
  • With Synapse 7x, organizations within the DoD network – now including Naval Medical Center - San Diego - will be able to access the diagnostic PACS platform that extends across the enterprise, an evolution from a radiology-specific PACS platform.
  • This award includes Navy Medical Center San Diego, Camp Pendleton, 29 Palms, Lemoore, plus approximately 40 additional medical treatment facilities will consolidate PACS vendors to have Fujifilm become the sole provider, streamlining patient imaging and data across the entire network.

Fujifilm Receives PACS Award for Naval Medical Center - San Diego

Retrieved on: 
Tuesday, February 20, 2024
Enterprise imaging, DOD, Cardiology, 3D, Radiology, Authority, Health, Fujifilm, Mammography, Organization, RMF, Risk Management Framework, PACS, Synapse, Medical imaging

Lexington, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, today announced that the company was selected to transform the enterprise radiology PACS at the Naval Medical Center - San Diego with Synapse® 7x – Fujifilm’s next-generation enterprise imaging platform.

Key Points: 
  • Lexington, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, today announced that the company was selected to transform the enterprise radiology PACS at the Naval Medical Center - San Diego with Synapse® 7x – Fujifilm’s next-generation enterprise imaging platform.
  • Synapse 7x unites data and imaging from radiology, mammography, cardiology, 3D and other enterprise imaging solutions on server-side rendering technology.
  • With Synapse 7x, organizations within the DoD network – now including Naval Medical Center - San Diego - will be able to access the diagnostic PACS platform that extends across the enterprise, an evolution from a radiology-specific PACS platform.
  • This award includes Navy Medical Center San Diego, Camp Pembleton, 29 Palms, Lemoore, plus approximately 40 additional medical treatment facilities will consolidate PACS vendors to have Fujifilm become the sole provider, streamlining patient imaging and data across the entire network.

Fujifilm Celebrates Recent Recipients of Fujifilm Fellowships at Harvard Medical School

Retrieved on: 
Tuesday, February 20, 2024
Lilium, Therapy, Research, Doctor of Philosophy, Drug resistance, Chemical biology, G protein-coupled receptor, Biology, Obesity, Pain, MIT, Harvard University, Drug discovery, Eurosport 1, Health, Fujifilm, Faculty (division), Disease, Massachusetts General Hospital, Harvard Medical School, Infection, Publication, Faculty, Fujifilm Diosynth Biotechnologies, Management

CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Holdings America Corporation (Fujifilm), today announced the nine most recent Fujifilm Fellows at Harvard Medical School.

Key Points: 
  • CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Holdings America Corporation (Fujifilm), today announced the nine most recent Fujifilm Fellows at Harvard Medical School.
  • These PhD students from around the world are part of the Harvard Medical School Therapeutics Graduate Program working to advance therapeutics discovery, development, and applications to improve the treatment of disease.
  • Launched with six fellows in 2019, the Fujifilm Fellowship has now grown to reach 34 recipients to date, including six alumni.
  • “Fujifilm is proud to support Harvard Medical School as it helps to shape our world’s future scientists.

Electronic Chemicals and Materials Market worth $77.8 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, March 7, 2024
Semiconductor, Chip on board, Acetic acid, Polychlorinated biphenyl, Silicon, PPB, Miniaturization, Health, Internet of things, Growth, ICS, Electronics, Plant, BASF, PPT, Printed circuit board, Space research, Linde plc, Integrated circuit packaging, Integrated circuit, Fujifilm, Air Liquide, Air Products, PCB, Tablet, Merck Group

Additionally, the trend towards miniaturization of electronic devices and the need for high-performance, reliable PCBs are contributing to the growth of the electronic chemicals and materials market.

Key Points: 
  • Additionally, the trend towards miniaturization of electronic devices and the need for high-performance, reliable PCBs are contributing to the growth of the electronic chemicals and materials market.
  • Semiconductor application segment of the electronic chemicals and materials market is expected to register the highest CAGR during the forecast period.
  • The semiconductor application segment within the electronic chemicals and materials market is anticipated to experience the highest Compound Annual Growth Rate (CAGR) throughout the forecast period.
  • North America accounts for the 2nd largest share in terms of the value of the electronic chemicals and materials market.

Electronic Chemicals and Materials Market worth $77.8 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, March 7, 2024
Semiconductor, Chip on board, Acetic acid, Polychlorinated biphenyl, Silicon, PPB, Miniaturization, Health, Internet of things, Growth, ICS, Electronics, Plant, BASF, PPT, Printed circuit board, Space research, Linde plc, Integrated circuit packaging, Integrated circuit, Fujifilm, Air Liquide, Air Products, PCB, Tablet, Merck Group

Additionally, the trend towards miniaturization of electronic devices and the need for high-performance, reliable PCBs are contributing to the growth of the electronic chemicals and materials market.

Key Points: 
  • Additionally, the trend towards miniaturization of electronic devices and the need for high-performance, reliable PCBs are contributing to the growth of the electronic chemicals and materials market.
  • Semiconductor application segment of the electronic chemicals and materials market is expected to register the highest CAGR during the forecast period.
  • The semiconductor application segment within the electronic chemicals and materials market is anticipated to experience the highest Compound Annual Growth Rate (CAGR) throughout the forecast period.
  • North America accounts for the 2nd largest share in terms of the value of the electronic chemicals and materials market.